PFIZER REPORTS FIRST-QUARTER 2017 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- US stock futures down as Middle East strikes fuel inflation anxiety
- Oil rises over 3% as US, Iran resumes military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Pfizer (PFE) Tops Q1 EPS by 2c, Offers FY Guidance
May 2, 2017 6:47 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.69, $0.02 better than the analyst estimate of $0.67. Revenue for the quarter came in at $12.8 billion versus the consensus estimate of $13.09 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.50-$2.60, versus the consensus of $2.55. Pfizer sees... More
